http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3044102-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56618388f2328e749c6940f048b40210
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0455
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
filingDate 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13d5a99d29fb7630b038eb664d216091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c6ef14528acfd81cbb871cc904282c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46dcb73762493423f26f86fbbd8701b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b0c9c6e88c9f1466cf50b38830ef385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_448bac1e68bee724702ab3b45b22a7c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f68188fb533983be44782739a2ebcbf
publicationDate 2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3044102-A1
titleOfInvention Precursors for radiofluorination
abstract The invention relates to a method for producing a radiofluorinated compound which has an aromatic or heteroaromatic ring which carries [18F] fluorine as the first substituent, a bonding unit which can bond to a peptide or a peptide mimetic, and a spacer group which connects the aromatic or heteroaromatic ring to the bonding unit, the bonding unit carrying at least one second substituent selected from the group consisting of -OH, -CONH and -COOH, the bonding unit being connected to the spacer group via a bond A1, and the spacer group being connected to the aromatic or heteroaromatic ring via a bond A2. According to the invention, the method comprises the following steps: (a) providing a precursor which has the aromatic or heteroaromatic ring which carries a substituent Y, the bonding unit which can bond to the peptide or the peptide mimetic and carries the at least one second substituent, and the spacer group, wherein the substituent Y is selected from the group consisting of -N+(R1R2R3), -NO2, -Cl, -Br, -F or -I, and R1, R2 and R3 are identical to or different from one another and are each unsubstituted or substituted C1-C6 alkyl; and (b) reacting the precursor with an [18F] fluoride anion in the presence of an activation salt to produce the radiofluorinated compound, wherein the substituent Y is replaced by [18F] fluorine and wherein the activation salt has a cation of the general formula N+(R4R5R6R7), where R4, R5, R6 and R7 are identical to or different from one another and are each unsubstituted or substituted C1-C6 alkyl.
priorityDate 2016-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22056947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105162
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID53320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3424274
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID85309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3782034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3681305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411888045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449653646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21940349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414804309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450067302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453253805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453784485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559561
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID419011
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3716971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452650124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68614
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450136125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450918453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 72.